TLR5 is expressed in LNCaP and DU145 cells, and its activation induces the production of chemokines that recruit immune effector cells, including NK cells and cytotoxic CD8+ T cells, which are likely to contribute to tumor suppression (39). Here, CD8A is linked to neoplasm.